STOCKSCOPE

Janus Electric (ASX: JNS) Has a $64.6 Million Truck Order Book, but Can It Turn Deliveries Into Cash?

Mark Elzayed

Mark Elzayed

CIO at Vestra Capital

Published:5d ago
Janus Electric (ASX: JNS) Has a $64.6 Million Truck Order Book, but Can It Turn Deliveries Into Cash?

Janus Electric Holdings Ltd (ASX: JNS) is approaching a critical commercial milestone, with its North American order book reaching approximately $64.6 million as production begins for its first US truck deliveries.

New banking facilities, strategic battery partnerships and additional customer orders have strengthened its expansion plans. However, substantial operating cash outflows raise an important question: can Janus convert its growing commercial pipeline into sustainable revenue before funding pressures intensify?

Key numbers

  • $64.6 million: Gross North American order book covering 124 heavy-duty trucks.
  • $11 million: Commonwealth Bank facilities secured to support production, equipment and working capital.
  • $7.68 million: July 2026 equity placement, generating approximately $7.2 million in net proceeds.
  • $3.04 million: Cash reserves at 30 September 2026.
  • $5.89 million: Net operating cash outflow during the September quarter.

A $3.1 million repeat order strengthens Janus's US expansion

Janus secured a $3.1 million repeat order from King Fio Trucking on 27 October 2026, covering six additional Class 8 electric truck conversions and six JBS-650 swappable battery sets.

The agreement lifted King Fio's commitment to 12 trucks and increased Janus's North American order book to 124 vehicles.

Importantly, the additional order remains conditional on applicable California electrification incentives. The broader $64.6 million order book therefore represents potential contract revenue rather than guaranteed sales.

Janus converts existing diesel-powered heavy trucks into electric vehicles using interchangeable battery systems. Its technology allows operators to swap depleted batteries instead of waiting for conventional charging, potentially improving fleet utilisation.

Beyond vehicle conversions, the business offers opportunities in battery supply, charging infrastructure and associated services.

On 26 October, Janus also signed a non-binding memorandum of understanding with ConGlobal for a proposed 20-truck pilot in Texas.

ConGlobal's network of 31 US depots provides potential expansion opportunities, although the pilot has not become a binding commercial order.

$11 million in banking facilities changes the funding equation

Janus secured $11 million in Commonwealth Bank financing facilities on 23 October, comprising $10 million in revolving trade finance and $1 million in asset finance.

Battery technology partner Electrovaya subsequently agreed to a $2 million strategic equity placement, subject to completion conditions.

The companies also established a strategic supply arrangement involving approximately $37.5 million in initial battery purchase orders, with commitments dependent on confirmed delivery schedules.

These arrangements support Janus's manufacturing ambitions but introduce substantial procurement and working capital requirements.

Funding strengthened during the September quarter following the completion of a $7.68 million equity placement in July, generating approximately $7.2 million after costs.

Despite this capital raising, cash reserves stood at $3.04 million on 30 September 2026, compared with $2.03 million three months earlier.

The company's September quarterly report recorded customer receipts of just $136,000 against net operating cash outflows of $5.89 million.

That expenditure included inventory purchases, creditor repayments and historical tax obligations. Management calculated adjusted operating outflows of approximately $3.71 million after excluding selected items.

The figures demonstrate why converting orders into customer payments is increasingly important.

Revenue is growing, but profitability remains elusive

Janus reported FY2026 revenue and other income of $4.81 million, approximately 53% higher than the previous year's $3.14 million.

However, its statutory net loss widened to $9.11 million from $8.91 million.

This divergence shows that commercial expansion has not yet translated into sustainable profitability.

An approximately $1.91 million research and development tax refund received in October helped reduce borrowings from around $4 million to $2.1 million, with expected annual interest savings of approximately $325,000.

Nevertheless, conventional earnings-based valuation measures remain unsuitable while the business records losses.

We believe contract conversion, gross margins, funding requirements and operating cash generation provide more meaningful measures of Janus's emerging commercial value.

Can Janus deliver 18 North American trucks before year-end?

Management is targeting delivery of 18 operational trucks across three North American fleets before the end of December 2026.

Successful completion would increase its combined Australian and North American operational fleet to approximately 46 vehicles.

Battery production has commenced in North America, supporting preparations for customer deliveries.

The next quarterly report should reveal whether those deliveries generate meaningful customer receipts, reduce operating cash burn and improve working capital efficiency.

Delays involving government incentives, manufacturing schedules or customer acceptance remain significant risks.

Insight: The $64.6 million pipeline faces its first major financial test

What stands out to us is the contrast between Janus's substantial North American order book and its limited cash receipts. The $64.6 million pipeline demonstrates potential demand, but sustainable value creation depends on converting contracts into profitable deliveries without excessive additional funding. New financing provides greater flexibility, although it does not eliminate execution risk. We see the strongest evidence of progress emerging from the next quarterly report, particularly customer receipts, delivered truck numbers and whether operating cash outflows begin declining.

The verdict: Deliveries must now justify the expansion

Janus has strengthened its commercial pipeline, financing arrangements and North American supply chain.

However, its substantial operating losses and cash requirements mean the opportunity remains highly dependent on execution.

Successful delivery of 18 trucks by December 2026, followed by stronger customer collections, would provide important evidence that commercial progress is translating into financial performance.

Until then, cash conversion remains the defining test of Janus Electric's growth ambitions.

Mark Elzayed

Mark Elzayed

(CIO at Vestra Capital)

Mark Elzayed is a prominent Australian financial executive and portfolio strategist with over a decade of hands-on capital markets experience. Having successfully managed over $100M+ in FUM across volatile economic cycles, Mark founded Vestra Capital to democratize institutional-grade quantitative strategies and privileged ASX deal flow for Australian investors.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore
Market Briefings
Market Briefings

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore

Australian equities: what moved the ASX 200? Australian shares finished lower on Friday, 6 November, as the technology-led sell-off on Wall Street spread across global markets. The ASX 200...

Mark ElzayedMark Elzayed•
Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test
Biotech & Health
Biotech & Health

Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test

Epiminder Limited ASX: EPI has expanded the US market for its epilepsy monitoring technology following a significant regulatory clearance, strengthening its commercial prospects ahead of a p...

Danny AadDanny Aad•
Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?
Mining
Mining

Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?

A 38-metre gold intersection grading 2.1 grams per tonne has given Asara Resources Limited ASX: AS1 an encouraging exploration result beyond its established Massan deposit in Guinea. The dis...

Alison ElzayedAlison Elzayed•
Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?
Mining
Mining

Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?

Alvo Minerals Limited ASX: ALV has extended rare earth mineralisation approximately 2 kilometres beyond previously tested areas at its Boa Vista prospect in Brazil, strengthening the explora...

Alison ElzayedAlison Elzayed•
Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet
Mining
Mining

Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet

Avenira Limited ASX: AEV has reached a significant financing milestone, with its $48.9 million rights issue providing fresh capital to advance the Wonarah Phosphate Project in the Northern T...

Alison ElzayedAlison Elzayed•
Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?
Biotech & Health
Biotech & Health

Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?

Mayne Pharma Group Limited ASX: MYX is taking a decisive step towards becoming a US-focused pharmaceutical company, agreeing to sell its international operations for $55.5 million. The tran...

Danny AadDanny Aad•
Loading more stories...